413 related articles for article (PubMed ID: 30577861)
1. Development of a novel oil-in-water emulsion and evaluation of its potential adjuvant function in a swine influenza vaccine in mice.
Zhang J; Miao J; Han X; Lu Y; Deng B; Lv F; Zhao Y; Ding C; Hou J
BMC Vet Res; 2018 Dec; 14(1):415. PubMed ID: 30577861
[TBL] [Abstract][Full Text] [Related]
2. A novel oil-in-water emulsion as a potential adjuvant for influenza vaccine: development, characterization, stability and in vivo evaluation.
Deng J; Cai W; Jin F
Int J Pharm; 2014 Jul; 468(1-2):187-95. PubMed ID: 24704309
[TBL] [Abstract][Full Text] [Related]
3. Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy.
Fox CB; Barnes V L; Evers T; Chesko JD; Vedvick TS; Coler RN; Reed SG; Baldwin SL
Influenza Other Respir Viruses; 2013 Sep; 7(5):815-26. PubMed ID: 23122325
[TBL] [Abstract][Full Text] [Related]
4. O/W Nanoemulsion as an Adjuvant for an Inactivated H3N2 Influenza Vaccine: Based on Particle Properties and Mode of Carrying.
Zhao L; Zhu Z; Ma L; Li Y
Int J Nanomedicine; 2020; 15():2071-2083. PubMed ID: 32273703
[TBL] [Abstract][Full Text] [Related]
5. Adjuvanted inactivated influenza A(H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines.
Ann J; Samant M; Rheaume C; Dumas C; Beaulieu E; Morasse A; Mallett C; Hamelin ME; Papadopoulou B; Boivin G
Vaccine; 2014 Sep; 32(43):5730-9. PubMed ID: 25173481
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, immunogenicity and stability of a novel intranasal nanoemulsion-adjuvanted influenza vaccine in a murine model.
Hamouda T; Chepurnov A; Mank N; Knowlton J; Chepurnova T; Myc A; Sutcliffe J; Baker JR
Hum Vaccin; 2010 Jul; 6(7):585-94. PubMed ID: 20421727
[TBL] [Abstract][Full Text] [Related]
7. AF03, an alternative squalene emulsion-based vaccine adjuvant prepared by a phase inversion temperature method.
Klucker MF; Dalençon F; Probeck P; Haensler J
J Pharm Sci; 2012 Dec; 101(12):4490-500. PubMed ID: 22941944
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.
Ott G; Barchfeld GL; Van Nest G
Vaccine; 1995 Nov; 13(16):1557-62. PubMed ID: 8578842
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
[TBL] [Abstract][Full Text] [Related]
10. A novel non-mineral oil-based adjuvant. II. Efficacy of a synthetic sulfolipopolysaccharide in a squalane-in-water emulsion in pigs.
Hilgers LA; Platenburg PL; Luitjens A; Groenveld B; Dazelle T; Weststrate MW
Vaccine; 1994 May; 12(7):661-5. PubMed ID: 8085386
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine.
Patil HP; Murugappan S; ter Veer W; Meijerhof T; de Haan A; Frijlink HW; Wilschut J; Hinrichs WL; Huckriede A
J Control Release; 2014 Jan; 174():51-62. PubMed ID: 24269505
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel oil-in-water emulsion adjuvant for swine influenza virus and Mycoplasma hyopneumoniae vaccines.
Galliher-Beckley A; Pappan LK; Madera R; Burakova Y; Waters A; Nickles M; Li X; Nietfeld J; Schlup JR; Zhong Q; McVey S; Dritz SS; Shi J
Vaccine; 2015 Jun; 33(25):2903-8. PubMed ID: 25936722
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.
Vesikari T; Kirstein J; Devota Go G; Leav B; Ruzycky ME; Isakov L; de Bruijn M; Oberye J; Heijnen E
Lancet Respir Med; 2018 May; 6(5):345-356. PubMed ID: 29631857
[TBL] [Abstract][Full Text] [Related]
14. An alternative renewable source of squalene for use in emulsion adjuvants.
Brito LA; Chan M; Baudner B; Gallorini S; Santos G; O'Hagan DT; Singh M
Vaccine; 2011 Aug; 29(37):6262-8. PubMed ID: 21723355
[TBL] [Abstract][Full Text] [Related]
15. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
Wack A; Baudner BC; Hilbert AK; Manini I; Nuti S; Tavarini S; Scheffczik H; Ugozzoli M; Singh M; Kazzaz J; Montomoli E; Del Giudice G; Rappuoli R; O'Hagan DT
Vaccine; 2008 Jan; 26(4):552-61. PubMed ID: 18162266
[TBL] [Abstract][Full Text] [Related]
16. The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect.
Calabro S; Tritto E; Pezzotti A; Taccone M; Muzzi A; Bertholet S; De Gregorio E; O'Hagan DT; Baudner B; Seubert A
Vaccine; 2013 Jul; 31(33):3363-9. PubMed ID: 23684834
[TBL] [Abstract][Full Text] [Related]
17. Sulfolipo-cyclodextrin in squalane-in-water as a novel and safe vaccine adjuvant.
Hilgers LA; Lejeune G; Nicolas I; Fochesato M; Boon B
Vaccine; 1999 Jan; 17(3):219-28. PubMed ID: 9987157
[TBL] [Abstract][Full Text] [Related]
18. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
[TBL] [Abstract][Full Text] [Related]
19. Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization.
Stark FC; Akache B; Ponce A; Dudani R; Deschatelets L; Jia Y; Sauvageau J; Williams D; Jamshidi MP; Agbayani G; Wachholz K; Harrison BA; Li X; Krishnan L; Chen W; McCluskie MJ
Vaccine; 2019 Nov; 37(47):7108-7116. PubMed ID: 31383490
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant effects of sulfolipo-cyclodextrin in a squalane-in-water and water-in-mineral oil emulsions for BHV-1 vaccines in cattle.
Romera SA; Hilgers LA; Puntel M; Zamorano PI; Alcon VL; Dus Santos MJ; Blanco Viera J; Borca MV; Sadir AM
Vaccine; 2000 Aug; 19(1):132-41. PubMed ID: 10924795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
